Please provide your email address to receive an email when new articles are posted on . Delayed presentation of 24 hours or more after non-STEMI symptom onset was associated with greater risk for ...

Please provide your email address to receive an email when new articles are posted on . Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates ...

Higher in-hospital mortality was seen for young women than young men for both STEMI, non-STEMI. HealthDay News — Among young adults, first ST-segment elevation myocardial infarction (STEMI) ...

"So that led to much higher mortality rates than seen in previous studies," Roe added. Unadjusted in-hospital mortality rates were 12.5% for non-STEMI patients and 14.3% for STEMI patients (p<0.001).

Trial assessed outcomes of quitting therapy after 1 year among select MI survivors ...

SAN FRANCISCO -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, there was no clinical benefit to a strategy of finding and treating all nonculprit ...

Noninferiority was not demonstrated between immediate and staged complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease undergoing ...

The 6000-patient BRIGHT-4 trial from China is prompting a rethink on bivalirudin in cath labs around the world and whether it should be the first-choice anticoagulant in primary percutaneous coronary ...

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel ...

Higher in-hospital mortality was seen for young women than young men for both STEMI, non-STEMI. (HealthDay News) — Among young adults, first ST-segment elevation myocardial infarction (STEMI) ...